Vitamin B6 (Pyridoxine) Deficiency

Overview


Plain-Language Overview

Vitamin B6 deficiency occurs when the body lacks enough pyridoxine, an important vitamin that helps the body make neurotransmitters and red blood cells. This deficiency can cause symptoms like irritability, confusion, and numbness in the hands and feet. People may also experience cracks at the corners of the mouth and a swollen tongue. It can happen due to poor diet, certain medical conditions, or medications that interfere with vitamin B6 absorption. Early recognition is important because treatment with vitamin B6 supplements can reverse symptoms.

Clinical Definition

Vitamin B6 deficiency is a clinical condition characterized by insufficient levels of pyridoxine, a water-soluble vitamin essential for amino acid metabolism, neurotransmitter synthesis, and hemoglobin production. It commonly presents with neurological symptoms such as peripheral neuropathy, characterized by numbness, paresthesias, and ataxia, as well as neuropsychiatric manifestations including irritability, depression, and confusion. Hematologic abnormalities may include microcytic anemia due to impaired heme synthesis. Glossitis and cheilitis are common mucocutaneous signs. Causes include inadequate dietary intake, malabsorption syndromes, chronic alcoholism, renal failure, and use of certain drugs like isoniazid and hydralazine that interfere with vitamin B6 metabolism. Diagnosis is supported by low plasma pyridoxal phosphate levels and clinical presentation. Treatment involves supplementation with pyridoxine, which typically leads to symptom resolution if initiated early. Untreated deficiency can result in irreversible neurological damage.

Inciting Event

  • Initiation of isoniazid therapy without pyridoxine supplementation.
  • Onset of chronic diarrhea or malabsorption reducing vitamin B6 absorption.
  • Excessive alcohol consumption leading to impaired metabolism.
  • Increased nutritional demand during pregnancy or lactation.
  • Development of autoimmune diseases affecting gut function.

Latency Period

  • Symptoms typically develop over weeks to months of inadequate vitamin B6 levels.

Diagnostic Delay

  • Neurological symptoms are often nonspecific and attributed to other causes.
  • Lack of routine screening for vitamin B6 levels in at-risk populations.
  • Overlap with symptoms of other nutritional deficiencies delays diagnosis.
  • Low clinical suspicion in patients without classic risk factors.

Clinical Presentation


Signs & Symptoms

  • Peripheral neuropathy characterized by numbness, tingling, and burning sensations.
  • Cheilitis and glossitis causing oral discomfort and pain.
  • Irritability and depression due to central nervous system involvement.
  • Seizures in severe deficiency cases.

History of Present Illness

  • Patients report paresthesias and numbness in the hands and feet.
  • Complaints of irritability, depression, or confusion may be present.
  • Muscle weakness and seizures can occur in severe cases.
  • Symptoms of microcytic anemia such as fatigue and pallor.
  • History of poor diet, alcohol use, or medication exposure.

Past Medical History

  • History of alcohol use disorder or chronic liver disease.
  • Previous diagnosis of malabsorption syndromes like celiac disease.
  • Long-term use of antitubercular drugs such as isoniazid.
  • Chronic illnesses causing increased metabolic demand.
  • Prior episodes of nutritional deficiencies.

Family History

  • None; vitamin B6 deficiency is typically acquired rather than inherited.

Physical Exam Findings

  • Presence of symmetric peripheral neuropathy with decreased sensation in a glove-and-stocking distribution.
  • Signs of cheilitis and glossitis with a swollen, erythematous tongue.
  • Possible seborrheic dermatitis around the nose and mouth.

Diagnostic Workup


Diagnostic Criteria

Diagnosis of vitamin B6 deficiency is based on clinical features such as peripheral neuropathy, glossitis, and cheilitis combined with laboratory evidence of low plasma pyridoxal phosphate levels. Additional supportive findings include microcytic anemia and elevated homocysteine levels. A history of risk factors such as malnutrition, chronic alcoholism, or use of medications interfering with vitamin B6 metabolism strengthens the diagnosis. Response to pyridoxine supplementation further confirms the condition.

Pathophysiology


Key Mechanisms

  • Vitamin B6 deficiency impairs pyridoxal phosphate-dependent enzymatic reactions essential for amino acid metabolism and neurotransmitter synthesis.
  • Deficiency leads to decreased synthesis of neurotransmitters such as serotonin, dopamine, and GABA, causing neurological symptoms.
  • Impaired heme synthesis due to lack of pyridoxal phosphate results in microcytic anemia.
  • Accumulation of homocysteine occurs due to disrupted transsulfuration pathway, increasing cardiovascular risk.
InvolvementDetails
Organs Liver is involved in vitamin B6 metabolism and storage, and dysfunction can exacerbate deficiency.
Brain is affected due to impaired neurotransmitter synthesis causing neurological symptoms in vitamin B6 deficiency.
Tissues Peripheral nerves are commonly affected, resulting in sensory neuropathy in vitamin B6 deficiency.
Bone marrow may show ineffective erythropoiesis leading to anemia in vitamin B6 deficiency.
Cells Neurons are affected by vitamin B6 deficiency due to impaired neurotransmitter synthesis leading to neuropathy.
Red blood cells may show microcytic anemia due to disrupted heme synthesis in vitamin B6 deficiency.
Chemical Mediators Gamma-aminobutyric acid (GABA) synthesis is decreased in vitamin B6 deficiency, contributing to neurological symptoms.
Serotonin production is impaired due to lack of pyridoxal phosphate cofactor in vitamin B6 deficiency.

Treatment


Pharmacological Treatments

  • Pyridoxine (Vitamin B6) supplementation

    • Mechanism: Replenishes deficient vitamin B6 to restore normal enzymatic functions involved in amino acid metabolism and neurotransmitter synthesis
    • Side effects: neuropathy with excessive doses, photosensitivity

Non-pharmacological Treatments

  • Increase dietary intake of vitamin B6 rich foods such as poultry, fish, potatoes, and fortified cereals.
  • Address and manage underlying causes such as alcoholism or malabsorption syndromes to improve vitamin B6 status.

Prevention


Pharmacological Prevention

  • Supplementation with oral pyridoxine in at-risk populations such as patients on isoniazid.
  • Vitamin B6 supplementation during isoniazid therapy to prevent neuropathy.
  • Use of multivitamin preparations containing vitamin B6 in malnourished individuals.

Non-pharmacological Prevention

  • Maintaining a balanced diet rich in vitamin B6 sources such as poultry, fish, and fortified cereals.
  • Avoidance of excessive alcohol consumption to improve nutrient absorption.
  • Monitoring and managing underlying conditions causing malabsorption.

Outcome & Complications


Complications

  • Peripheral neuropathy progressing to irreversible nerve damage.
  • Seizures refractory to standard anticonvulsants.
  • Anemia due to impaired heme synthesis.
  • Impaired immune function increasing infection risk.
Short-term SequelaeLong-term Sequelae
  • Paresthesias and sensory disturbances in extremities.
  • Oral mucosal inflammation causing pain and difficulty eating.
  • Mood changes including irritability and mild depression.
  • Chronic peripheral neuropathy with motor weakness and sensory loss.
  • Neuropsychiatric disorders including severe depression and cognitive impairment.
  • Irreversible neurological damage if untreated.

Differential Diagnoses


Vitamin B6 (Pyridoxine) Deficiency versus Iron Deficiency Anemia

Vitamin B6 (Pyridoxine) DeficiencyIron Deficiency Anemia
Normocytic or microcytic anemia with normal iron studies and elevated homocysteineMicrocytic hypochromic anemia with low serum ferritin and increased total iron-binding capacity (TIBC)
Peripheral neuropathy and seizures may be present due to impaired neurotransmitter synthesisPica and koilonychia (spoon nails) are common clinical features
Characteristic cheilitis, glossitis, and seborrheic dermatitis are typical of vitamin B6 deficiencyNo associated neurologic symptoms such as peripheral neuropathy or seizures

Vitamin B6 (Pyridoxine) Deficiency versus Niacin (Vitamin B3) Deficiency

Vitamin B6 (Pyridoxine) DeficiencyNiacin (Vitamin B3) Deficiency
Peripheral neuropathy with seizures and irritability is more typical of vitamin B6 deficiencyPellagra characterized by the triad of dermatitis, diarrhea, and dementia
Characteristic cheilitis, glossitis, and seborrheic dermatitis without the classic pellagra triadSymmetric, photosensitive dermatitis with hyperpigmentation and scaling in sun-exposed areas
Laboratory findings show elevated homocysteine and decreased pyridoxal phosphate levelsNeuropsychiatric symptoms include depression, headache, and memory loss rather than peripheral neuropathy

Vitamin B6 (Pyridoxine) Deficiency versus Vitamin B12 Deficiency

Vitamin B6 (Pyridoxine) DeficiencyVitamin B12 Deficiency
Microcytic or normocytic anemia without elevated methylmalonic acidMacrocytic anemia with hypersegmented neutrophils and elevated methylmalonic acid
Peripheral neuropathy primarily involving sensory neurons without spinal cord involvementSubacute combined degeneration of the spinal cord causing posterior column and corticospinal tract symptoms
Cheilitis, stomatitis, and seborrheic dermatitis are common without the classic neurologic signs of B12 deficiencyGlossitis with a smooth, beefy red tongue but often accompanied by neurologic deficits such as paresthesias

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.